Search results
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 3 days agoA bargain now If we exclude expected losses from Paxlovid... could grow sales by a high-single-digit...
Novavax's stock surges almost 300% in the past month
AOL· 18 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 days agoBiotech stock hit a two-year high in February, but have trended lower in the months since despite a...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) ( ...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 2 days agoThe conference was a big one for Summit Therapeutics, which saw its stock price more than double...
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 22 hours agoIn a filing with the Securities and Exchange Commission, Novavax said the FDA said it completed its...
Bird flu death in Mexico linked to strain not seen in humans before
Seeking Alpha· 2 days agoThe World Health Organization confirms the first human case of H5N2 bird flu in Mexico. Read more...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 2 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoNovavax, Inc. NVAX shares are trading higher Wednesday, and the stock is up by more than 300% over...
Novavax says it will have an updated Covid vaccine - Washington Business Journal
The Business Journals· 19 hours agoThe announcement followed the FDA’s Vaccines and Related Biological Products Advisory Committee’s...